ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT06806033

Public ClinicalTrials.gov record NCT06806033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Open-Label, Multicenter Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Patients With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Study identification

NCT ID
NCT06806033
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • Gemcitabine Drug
  • Glofitamab Drug
  • Obinutuzumab Drug
  • Oxaliplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2025
Primary completion
Jan 30, 2027
Completion
Mar 29, 2029
Last update posted
Apr 26, 2026

2025 – 2029

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Alaska Oncology & Hematology, LLC Anchorage Alaska 99508 Recruiting
Community Cancer Institute (CCI) Clovis California 93611 Recruiting
Providence Medical Foundation Fullerton California 92835 Recruiting
Los Angeles Cancer Network Glendale California 91204 Recruiting
Valkyrie Clinical Trials Los Angeles California 90067 Recruiting
Valkyrie Clinical Trials Panorama City California 91402 Recruiting
Zuckerberg San Francisco General Hospital San Francisco California 94110 Recruiting
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente Torrance California 90502-2006 Recruiting
Rocky Mountain Cancer Centers, LLP Aurora Colorado 80012 Recruiting
North Florida/ South Georgia VA Medical Center Gainesville Florida 32608 Recruiting
Mount Sinai Comprehensive Cancer Center Miami Florida 33140 Recruiting
Orlando Health Cancer Institute Orlando Florida 32806 Recruiting
St Luke?s Cancer Institute Boise Idaho 83712 Recruiting
Cancer Care Specialists of Central Illinois Swansea Illinois 62226 Recruiting
Mission Blood and Cancer - MercyOne Cancer Center Waukee Iowa 50263 Recruiting
University of Kentucky - Markey Cancer Center Lexington Kentucky 40536 Recruiting
Mary Bird Perkins Cancer Ctr Baton Rouge Louisiana 70809 Recruiting
Boston Medical Center Boston Massachusetts 02118 Recruiting
Nebraska Cancer Specialists Omaha Nebraska 68130 Recruiting
New York Oncology Hematology, P.C. Albany New York 12206 Recruiting
Hematology Oncology Associates of Central New York East Syracuse New York 13057 Recruiting
Oncology Associates of Oregon, P.C Eugene Oregon 97401 Recruiting
Providence Portland Medical Center Portland Oregon 97213 Recruiting
Providence St. Vincent Medical Center Portland Oregon 97225 Recruiting
Tennessee Oncology Chattanooga Tennessee 37403 Recruiting
Tennessee Oncology Nashville Tennessee 37203 Recruiting
Baylor Scott & White Health Temple Texas 76502 Recruiting
Texas Oncology - Gulf Coast The Woodlands Texas 77380 Recruiting
Texas Oncology- Northeast Texas Tyler Texas 75702 Recruiting
Virginia Cancer Specialists, PC Fairfax Virginia 22031 Recruiting
Virginia Oncology Associates - Virginia Beach Virginia Beach Virginia 23456 Recruiting
Northwest Medical Specialties Tacoma Washington 98405 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06806033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06806033 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →